{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:52:13Z","timestamp":1787503933990,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"KAKENHI Grans-in-Aid for Scientific Research C","award":["15K10388"],"award-info":[{"award-number":["15K10388"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10585-020-10053-z","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T09:05:04Z","timestamp":1596186304000},"page":"607-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prediction of pathological fracture in patients with lower limb bone metastasis using computed tomography imaging"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5489-2751","authenticated-orcid":false,"given":"Yusuke","family":"Shinoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ohki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masachika","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Okajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotake","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"10053_CR1","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","volume":"362","author":"M Maemondo","year":"2010","unstructured":"Maemondo M, Inoue A, Kobayashi K et al (2010) Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 362:2380\u20132388","journal-title":"N Engl J Med"},{"key":"10053_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Long GV, Brady B et al (2015) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372:320\u2013330","journal-title":"N Engl J Med"},{"key":"10053_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0030-5898(05)70171-1","volume":"31","author":"WD Hage","year":"2000","unstructured":"Hage WD, Aboulafia AJ, Aboulafia DM (2000) Incidence, location, and diagnostic evaluation of metastatic bone disease. Orthop Clin N Am 31:515\u2013528","journal-title":"Orthop Clin N Am"},{"key":"10053_CR4","first-page":"148","volume":"312","author":"N Hosono","year":"1995","unstructured":"Hosono N, Yonenobu K, Fuji T, Ebara S, Yamashita K, Ono K (1995) Orthopaedic management of spinal metastases. Clin Orthop Relat Res 312:148\u2013159","journal-title":"Clin Orthop Relat Res"},{"key":"10053_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165\u2013167","journal-title":"Cancer Treat Rev"},{"key":"10053_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10585-019-09983-0","volume":"36","author":"Y Shinoda","year":"2019","unstructured":"Shinoda Y, Sawada R, Yoshikawa F et al (2019) Factors related to the quality of life in patients with bone metastases. Clin Exp Metastasis 36:441\u2013448","journal-title":"Clin Exp Metastasis"},{"key":"10053_CR7","doi-asserted-by":"publisher","first-page":"S230","DOI":"10.1097\/01.blo.0000093849.72468.82","volume":"415S","author":"WG Ward","year":"2003","unstructured":"Ward WG, Holsenbeck S, Dorey FJ, Spang J, Howe D (2003) Metastatic disease of the femur: surgical treatment. Clin Orthop Relat Res 415S:S230\u2013244","journal-title":"Clin Orthop Relat Res"},{"key":"10053_CR8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003086-198912000-00027","volume":"249","author":"H Mirels","year":"1989","unstructured":"Mirels H (1989) Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 249:256\u2013264","journal-title":"Clin Orthop Relat Res"},{"key":"10053_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0167-8140(03)00232-9","volume":"69","author":"YM Van der Linden","year":"2003","unstructured":"Van der Linden YM, Kroon HM, Dijkstra SP et al (2003) Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomized trial. Radiother Oncol 69:21\u201331","journal-title":"Radiother Oncol"},{"key":"10053_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/BLO.0b013e3180514caa","volume":"459","author":"JH Keyak","year":"2007","unstructured":"Keyak JH, Kaneko TS, Skinner HB et al (2007) The effect of simulated metastatic lytic lesions on proximal femoral strength. Clin Orthop Relat Res 459:139\u2013145","journal-title":"Clin Orthop Relat Res"},{"key":"10053_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jos.2019.08.014","volume":"24","author":"Y Shinoda","year":"2019","unstructured":"Shinoda Y, Kobayashi H, Kaneko M et al (2019) Prediction of the pathological fracture risk during stance and fall-loading configurations for metastases in the proximal femur, using a computed tomography-based finite element method. J Orthop Sci 24:1074\u20131080","journal-title":"J Orthop Sci"},{"key":"10053_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jos.2017.05.015","volume":"22","author":"Y Kawabata","year":"2017","unstructured":"Kawabata Y, Matsuo K, Nezu Y et al (2017) The risk assessment of pathological fracture in the proximal femur using a CT-based finite element method. J Orthop Sci 22:931\u2013937","journal-title":"J Orthop Sci"},{"key":"10053_CR13","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1097\/BOT.0b013e3182809748","volume":"27","author":"R Sivasundaram","year":"2013","unstructured":"Sivasundaram R, Shah S, Ahmadi S et al (2013) The biomechanical effect of proximal tumor defect location on femur pathological fractures. J Orthop Trauma 27:e174\u2013e180","journal-title":"J Orthop Trauma"},{"key":"10053_CR14","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/jor.23550","volume":"35","author":"E Benca","year":"2017","unstructured":"Benca E, Reisinger A, Patsch JM et al (2017) Effect of simulated metastatic lesions on the biomechanical behavior of the proximal femur. J Orthop Res 35:2407\u20132414","journal-title":"J Orthop Res"},{"key":"10053_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.bone.2009.06.009","volume":"45","author":"E Tanck","year":"2009","unstructured":"Tanck E, van Aken JB, van der Linden YM et al (2009) Pathological fracture prediction in patients with metastatic lesions can be improved with quantitative computed tomography based computer models. Bone 45:777\u2013783","journal-title":"Bone"},{"key":"10053_CR16","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","volume":"22","author":"T Hamaoka","year":"2004","unstructured":"Hamaoka T, Madewell JE, Podoloff DA et al (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942\u20132953","journal-title":"J Clin Oncol"},{"key":"10053_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/cam4.292","volume":"3","author":"H Katagiri","year":"2014","unstructured":"Katagiri H, Okada R, Takagi T et al (2014) New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med 3:1359\u20131367","journal-title":"Cancer Med"},{"key":"10053_CR18","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1388::AID-CNCR4>3.0.CO;2-H","volume":"78","author":"T Yamaguchi","year":"1996","unstructured":"Yamaguchi T, Tamai K, Yamato M et al (1996) Intertrabecular pattern of tumors metastatic to bone. Cancer 78:1388\u20131394","journal-title":"Cancer"},{"key":"10053_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-2001-15676","volume":"5","author":"T Yamaguchi","year":"2001","unstructured":"Yamaguchi T (2001) Intertrabecular vertebral metastases: metastases only detectable on MR imaging. Semin Musculoskelet Radiol 5:171\u2013175","journal-title":"Semin Musculoskelet Radiol"},{"key":"10053_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00003086-198209000-00008","volume":"169","author":"KD Harrington","year":"1982","unstructured":"Harrington KD (1982) New trends in the management of lower extremity metastases. Clin Orthop Relat Res 169:53\u201361","journal-title":"Clin Orthop Relat Res"},{"key":"10053_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00393714","volume":"116","author":"PD Dijkstra","year":"1997","unstructured":"Dijkstra PD, Oudkerk M, Wiggers T (1997) Prediction of pathological subtrochanteric fractures due to metastatic lesions. Arch Orthop Trauma Surg 116:221\u2013224","journal-title":"Arch Orthop Trauma Surg"},{"key":"10053_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jjco\/hyz028","volume":"49","author":"T Hirai","year":"2019","unstructured":"Hirai T, Shinoda Y, Tateishi R (2019) Early detection of bone metastases of hepatocellular carcinoma reduces bone fracture and paralysis. Jpn J Clin Oncol 49:529\u2013536","journal-title":"Jpn J Clin Oncol"},{"key":"10053_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3109\/17453678108992157","volume":"52","author":"M Fidler","year":"1981","unstructured":"Fidler M (1981) Incidence of fracture through metastases in long bones. Acta Orthop 52:623\u2013627","journal-title":"Acta Orthop"},{"key":"10053_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/17453678809169697","volume":"59","author":"H Menck","year":"1988","unstructured":"Menck H, Schulze S, Larsen E (1988) Metastasis size in pathologic femoral fractures. Acta Orthop 59:151\u2013154","journal-title":"Acta Orthop"},{"key":"10053_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13014-014-0227-1","volume":"9","author":"Z Tatar","year":"2014","unstructured":"Tatar Z, Soubrier M, Dillies AF et al (2014) Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study. Radiat Oncol 9:227","journal-title":"Radiat Oncol"},{"key":"10053_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.radonc.2016.03.001","volume":"119","author":"KH Groenen","year":"2016","unstructured":"Groenen KH, Pouw MH, Hannink G et al (2016) The effect of radiotherapy, and radiotherapy combined with bisphosphonates or RANK ligand inhibitors on bone quality in bone metastases. A systematic review. Radiother Oncol 119:194\u2013201","journal-title":"Radiother Oncol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-020-10053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-020-10053-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-020-10053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T05:09:55Z","timestamp":1667624995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-020-10053-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10053"],"URL":"https:\/\/doi.org\/10.1007\/s10585-020-10053-z","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was conducted according to the ethical guidelines for epidemiological research laid out by the Japanese Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labour and Welfare. The study protocol was included in a comprehensive protocol developed by the Department of Rehabilitation and the Department of Orthopaedic Surgery, the University of Tokyo Hospital. The study was approved by the University of Tokyo Medical Research Center Ethics Committee (approval number: 2373).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants were provided a means to opt out.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The datasets during and\/or analysed during the current study available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}